CN102516329A - 天麻素合成方法 - Google Patents
天麻素合成方法 Download PDFInfo
- Publication number
- CN102516329A CN102516329A CN2011103804044A CN201110380404A CN102516329A CN 102516329 A CN102516329 A CN 102516329A CN 2011103804044 A CN2011103804044 A CN 2011103804044A CN 201110380404 A CN201110380404 A CN 201110380404A CN 102516329 A CN102516329 A CN 102516329A
- Authority
- CN
- China
- Prior art keywords
- gastrodine
- recrystallization
- reaction
- add
- condenses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 28
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 title abstract 8
- 229930193974 gastrodin Natural products 0.000 title abstract 8
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 title abstract 8
- 230000002194 synthesizing effect Effects 0.000 title abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 106
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 97
- 238000006243 chemical reaction Methods 0.000 claims abstract description 97
- 238000001953 recrystallisation Methods 0.000 claims abstract description 68
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- NIBFJPXGNVPNHK-UHFFFAOYSA-N 2,2-difluoro-1,3-benzodioxole-4-carbaldehyde Chemical group C1=CC(C=O)=C2OC(F)(F)OC2=C1 NIBFJPXGNVPNHK-UHFFFAOYSA-N 0.000 claims abstract description 41
- 229960002246 beta-d-glucopyranose Drugs 0.000 claims abstract description 41
- -1 per-acetyl dextrose Chemical compound 0.000 claims abstract description 37
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000002904 solvent Substances 0.000 claims abstract description 36
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims abstract description 34
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 29
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 29
- 239000001257 hydrogen Substances 0.000 claims abstract description 29
- 229910000564 Raney nickel Inorganic materials 0.000 claims abstract description 28
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims abstract description 27
- 239000011734 sodium Substances 0.000 claims abstract description 23
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 21
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 claims abstract description 18
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims abstract description 17
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000002576 ketones Chemical class 0.000 claims abstract description 14
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 13
- 229960001031 glucose Drugs 0.000 claims abstract description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 claims description 52
- 238000004809 thin layer chromatography Methods 0.000 claims description 51
- 235000019441 ethanol Nutrition 0.000 claims description 40
- 239000012046 mixed solvent Substances 0.000 claims description 30
- 238000001514 detection method Methods 0.000 claims description 29
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 28
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 238000005406 washing Methods 0.000 claims description 24
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 21
- 238000005984 hydrogenation reaction Methods 0.000 claims description 21
- 125000001246 bromo group Chemical group Br* 0.000 claims description 17
- 125000002252 acyl group Chemical group 0.000 claims description 16
- 238000000967 suction filtration Methods 0.000 claims description 14
- 150000002148 esters Chemical class 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 239000003444 phase transfer catalyst Substances 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- 238000010511 deprotection reaction Methods 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 10
- 238000012544 monitoring process Methods 0.000 claims description 10
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 235000002639 sodium chloride Nutrition 0.000 claims description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical group [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 241000219095 Vitis Species 0.000 claims description 6
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 6
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 6
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 6
- 150000001272 acylglucoses Chemical class 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 238000011084 recovery Methods 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- 238000013019 agitation Methods 0.000 claims description 4
- 229940043232 butyl acetate Drugs 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- NUKZAGXMHTUAFE-UHFFFAOYSA-N hexanoic acid methyl ester Natural products CCCCCC(=O)OC NUKZAGXMHTUAFE-UHFFFAOYSA-N 0.000 claims description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 2
- 235000021050 feed intake Nutrition 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 239000008121 dextrose Substances 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 239000007868 Raney catalyst Substances 0.000 abstract 1
- 230000000397 acetylating effect Effects 0.000 abstract 1
- 229940089206 anhydrous dextrose Drugs 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- 229960003742 phenol Drugs 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 235000007715 potassium iodide Nutrition 0.000 description 3
- 229960004839 potassium iodide Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BVJSUAQZOZWCKN-UHFFFAOYSA-N p-hydroxybenzyl alcohol Chemical compound OCC1=CC=C(O)C=C1 BVJSUAQZOZWCKN-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- HXBYBCASAVUYKF-GVYWOMJSSA-N (4r,5s,6r,7r)-4,5,6,7,8-pentahydroxyoctane-2,3-dione Chemical compound CC(=O)C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HXBYBCASAVUYKF-GVYWOMJSSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- PRGNOEVQIUJKMX-UGXXJQIGSA-N OCC1=CC=C(C=C1)[C@]1(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO.O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO.C(O)C1=CC=CC=C1 Chemical compound OCC1=CC=C(C=C1)[C@]1(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO.O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO.C(O)C1=CC=CC=C1 PRGNOEVQIUJKMX-UGXXJQIGSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- RYVMUASDIZQXAA-UHFFFAOYSA-N pyranoside Natural products O1C2(OCC(C)C(OC3C(C(O)C(O)C(CO)O3)O)C2)C(C)C(C2(CCC3C4(C)CC5O)C)C1CC2C3CC=C4CC5OC(C(C1O)O)OC(CO)C1OC(C1OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OCC(O)C(O)C1O RYVMUASDIZQXAA-UHFFFAOYSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical group N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110380404.4A CN102516329B (zh) | 2011-11-25 | 2011-11-25 | 天麻素合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110380404.4A CN102516329B (zh) | 2011-11-25 | 2011-11-25 | 天麻素合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102516329A true CN102516329A (zh) | 2012-06-27 |
CN102516329B CN102516329B (zh) | 2014-03-26 |
Family
ID=46287445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110380404.4A Expired - Fee Related CN102516329B (zh) | 2011-11-25 | 2011-11-25 | 天麻素合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102516329B (zh) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102964403A (zh) * | 2012-12-03 | 2013-03-13 | 罗军 | 天麻素化合物及其药物组合物 |
CN102977161A (zh) * | 2012-12-17 | 2013-03-20 | 青岛农业大学 | 一种化学合成天麻素的方法 |
CN103224539A (zh) * | 2013-05-23 | 2013-07-31 | 湖北济生医药有限公司 | 一种天麻素化合物及其药物组合物 |
CN103275146A (zh) * | 2013-06-13 | 2013-09-04 | 青岛农业大学 | 一种适合于产业化的天麻素化学合成方法 |
CN103665057A (zh) * | 2013-11-30 | 2014-03-26 | 山东永泰化工有限公司 | 一种溴代四乙酰葡萄糖的合成方法 |
CN103804438A (zh) * | 2012-11-12 | 2014-05-21 | 昆明制药集团股份有限公司 | 一种高纯度、高稳定性天麻素的半合成方法 |
CN103896998A (zh) * | 2014-03-13 | 2014-07-02 | 广安凯特医药化工有限公司 | 天麻素中间体的制备方法及天麻素的合成方法 |
CN104447904A (zh) * | 2014-08-04 | 2015-03-25 | 昆明制药集团股份有限公司 | 一种口服生物利用度高的稳定天麻素晶体及其制备方法、制剂与应用 |
CN104744529A (zh) * | 2014-05-30 | 2015-07-01 | 昆明制药集团股份有限公司 | 一种适于工业化生产天麻素的高效高收率制备方法 |
CN106279311A (zh) * | 2016-08-23 | 2017-01-04 | 宜宾莱特医药化工有限公司 | 一种4‑ 羟甲基苯基 ‑β‑D 吡喃葡萄糖苷合成方法 |
CN108997454A (zh) * | 2018-09-05 | 2018-12-14 | 青岛农业大学 | 一种β-熊果苷的化学合成方法 |
CN112159441A (zh) * | 2020-10-15 | 2021-01-01 | 北京悦康科创医药科技股份有限公司 | 一种天麻素中间体的合成方法及应用 |
CN112538067A (zh) * | 2020-12-17 | 2021-03-23 | 北京悦康科创医药科技股份有限公司 | 一种四乙酰葡萄糖烯的制备方法 |
CN114573649A (zh) * | 2020-11-30 | 2022-06-03 | 昆药集团股份有限公司 | 一种高纯度的天麻素晶体及其制备方法和应用 |
CN114573647A (zh) * | 2020-11-30 | 2022-06-03 | 昆药集团股份有限公司 | 天麻素无水晶型及其制备方法 |
CN114685576A (zh) * | 2020-12-29 | 2022-07-01 | 昆药集团股份有限公司 | 高纯度天麻素不稳定晶型、其制备方法及天麻素晶型FormA的制备方法 |
CN114685575A (zh) * | 2020-12-29 | 2022-07-01 | 昆药集团股份有限公司 | 天麻素无水晶型及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1428345A (zh) * | 2002-11-22 | 2003-07-09 | 云大科技股份有限公司 | 制备天麻素及其类似酚性糖甙式(i)的化学合成工艺 |
CN101293905A (zh) * | 2008-06-16 | 2008-10-29 | 山西医科大学 | 苯并噁唑酮糖苷类化合物及其制备方法 |
CN102199176A (zh) * | 2011-04-12 | 2011-09-28 | 江苏澳新生物工程有限公司 | 2-氨基-2-脱氧-d-葡萄糖及其盐的制备方法 |
-
2011
- 2011-11-25 CN CN201110380404.4A patent/CN102516329B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1428345A (zh) * | 2002-11-22 | 2003-07-09 | 云大科技股份有限公司 | 制备天麻素及其类似酚性糖甙式(i)的化学合成工艺 |
CN101293905A (zh) * | 2008-06-16 | 2008-10-29 | 山西医科大学 | 苯并噁唑酮糖苷类化合物及其制备方法 |
CN102199176A (zh) * | 2011-04-12 | 2011-09-28 | 江苏澳新生物工程有限公司 | 2-氨基-2-脱氧-d-葡萄糖及其盐的制备方法 |
Non-Patent Citations (2)
Title |
---|
庞其捷等: "天麻素合成方法的改进", 《医药工业》 * |
戴晓畅等: "天麻素及其类似酚性糖甙的化学合成工艺研究", 《云南民族大学学报(自然科学版)》 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103804438A (zh) * | 2012-11-12 | 2014-05-21 | 昆明制药集团股份有限公司 | 一种高纯度、高稳定性天麻素的半合成方法 |
CN103804438B (zh) * | 2012-11-12 | 2016-09-07 | 昆药集团股份有限公司 | 一种高纯度、高稳定性天麻素的半合成方法 |
CN102964403A (zh) * | 2012-12-03 | 2013-03-13 | 罗军 | 天麻素化合物及其药物组合物 |
CN102964403B (zh) * | 2012-12-03 | 2014-07-09 | 北京康瑞达彤医药科技有限公司 | 天麻素化合物及其药物组合物 |
CN102977161A (zh) * | 2012-12-17 | 2013-03-20 | 青岛农业大学 | 一种化学合成天麻素的方法 |
CN102977161B (zh) * | 2012-12-17 | 2015-03-25 | 青岛农业大学 | 一种化学合成天麻素的方法 |
CN103224539B (zh) * | 2013-05-23 | 2015-09-09 | 湖北济生医药有限公司 | 一种天麻素化合物及其药物组合物 |
CN103224539A (zh) * | 2013-05-23 | 2013-07-31 | 湖北济生医药有限公司 | 一种天麻素化合物及其药物组合物 |
CN103275146A (zh) * | 2013-06-13 | 2013-09-04 | 青岛农业大学 | 一种适合于产业化的天麻素化学合成方法 |
CN103275146B (zh) * | 2013-06-13 | 2015-07-29 | 青岛农业大学 | 一种适合于产业化的天麻素化学合成方法 |
CN103665057A (zh) * | 2013-11-30 | 2014-03-26 | 山东永泰化工有限公司 | 一种溴代四乙酰葡萄糖的合成方法 |
CN103665057B (zh) * | 2013-11-30 | 2016-04-13 | 山东永泰化工有限公司 | 一种溴代四乙酰葡萄糖的合成方法 |
CN103896998A (zh) * | 2014-03-13 | 2014-07-02 | 广安凯特医药化工有限公司 | 天麻素中间体的制备方法及天麻素的合成方法 |
CN103896998B (zh) * | 2014-03-13 | 2016-08-24 | 广安凯特医药化工有限公司 | 天麻素中间体的制备方法及天麻素的合成方法 |
CN104744529A (zh) * | 2014-05-30 | 2015-07-01 | 昆明制药集团股份有限公司 | 一种适于工业化生产天麻素的高效高收率制备方法 |
CN104447904B (zh) * | 2014-08-04 | 2016-07-27 | 昆药集团股份有限公司 | 一种口服生物利用度高的稳定天麻素晶体及其制备方法、制剂与应用 |
CN104447904A (zh) * | 2014-08-04 | 2015-03-25 | 昆明制药集团股份有限公司 | 一种口服生物利用度高的稳定天麻素晶体及其制备方法、制剂与应用 |
CN106279311A (zh) * | 2016-08-23 | 2017-01-04 | 宜宾莱特医药化工有限公司 | 一种4‑ 羟甲基苯基 ‑β‑D 吡喃葡萄糖苷合成方法 |
CN106279311B (zh) * | 2016-08-23 | 2018-08-14 | 宜宾莱特医药化工有限公司 | 一种4-羟甲基苯基-β-D吡喃葡萄糖苷合成方法 |
CN108997454A (zh) * | 2018-09-05 | 2018-12-14 | 青岛农业大学 | 一种β-熊果苷的化学合成方法 |
CN108997454B (zh) * | 2018-09-05 | 2023-03-21 | 青岛农业大学 | 一种β-熊果苷的化学合成方法 |
CN112159441A (zh) * | 2020-10-15 | 2021-01-01 | 北京悦康科创医药科技股份有限公司 | 一种天麻素中间体的合成方法及应用 |
CN114573649A (zh) * | 2020-11-30 | 2022-06-03 | 昆药集团股份有限公司 | 一种高纯度的天麻素晶体及其制备方法和应用 |
CN114573647A (zh) * | 2020-11-30 | 2022-06-03 | 昆药集团股份有限公司 | 天麻素无水晶型及其制备方法 |
CN112538067A (zh) * | 2020-12-17 | 2021-03-23 | 北京悦康科创医药科技股份有限公司 | 一种四乙酰葡萄糖烯的制备方法 |
CN114685576A (zh) * | 2020-12-29 | 2022-07-01 | 昆药集团股份有限公司 | 高纯度天麻素不稳定晶型、其制备方法及天麻素晶型FormA的制备方法 |
CN114685575A (zh) * | 2020-12-29 | 2022-07-01 | 昆药集团股份有限公司 | 天麻素无水晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102516329B (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102516329B (zh) | 天麻素合成方法 | |
CN103739504B (zh) | 一种重酒石酸间羟胺的合成方法 | |
CN101735190B (zh) | 一种制备黄芩素的方法 | |
CN103664536A (zh) | 一种羟基酪醇的合成方法 | |
CN103319414A (zh) | 替米沙坦制备工艺的改进 | |
CN102351921A (zh) | 一种新橙皮苷二氢查耳酮的制备方法 | |
CN102079737B (zh) | 一种制备芹菜素的方法 | |
CN101066912B (zh) | 一种反式多羟基二苯乙烯的制备方法 | |
CN102060860A (zh) | 一种马波沙星的制备方法 | |
CN103180325B (zh) | 制备β-蒿甲醚的方法 | |
CN101284769B (zh) | 高血压药阿利克仑主要中间体化合物的合成方法 | |
CN103601701A (zh) | 一种左旋氯哌斯汀芬地柞酸盐的制备方法 | |
CN101891595A (zh) | 一种羟基酪醇的制备方法 | |
CN105348063A (zh) | 一种药用丹皮酚合成和精制新方法 | |
CN104478972B (zh) | 一种采用自吸式搅拌高压釜制备曲克芦丁的方法 | |
CN103524575A (zh) | 一种改进的β-熊果苷制备方法 | |
CN101845066A (zh) | 卡培他滨中间体5-脱氧-d-呋喃核糖的合成方法 | |
CN102180773A (zh) | 一种白藜芦醇的制备方法 | |
CN101712594A (zh) | 2-环己基-5-(1,1-二甲辛基)苯酚及其合成方法 | |
CN102093323B (zh) | 槲皮素的制备方法 | |
CN103724217A (zh) | 一种d-酪氨酸的不对称合成方法 | |
CN105198734B (zh) | 一种制备没食子酸的方法 | |
CN101348444B (zh) | 2-乙氧基-4-乙酰胺基苯甲酸甲酯的制备方法 | |
CN102373250B (zh) | 阿伐他汀钙侧链中间体的制备方法 | |
CN105884625A (zh) | 一种r-沙美特罗的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiang Zhengxiang Inventor after: Diao Wenrui Inventor after: Chen Hong Inventor after: Song Zhenfeng Inventor after: Tang Qiuling Inventor after: Yu Hexian Inventor after: Wang Qianli Inventor before: Jiang Zhengxiang Inventor before: Wang Qianli Inventor before: Diao Wenrui Inventor before: Song Zhenfeng Inventor before: Yu Hexian Inventor before: Chen Hong Inventor before: Zhang Feng Inventor before: Shao Guanru Inventor before: Wang Xiying |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIANG ZHENGXIANG WANG QIANLI DIAO WENRUI SONG ZHENFENG YU HEXIAN CHEN HONG ZHANG FENG SHAO GUANRU WANG XIYING TO: JIANG ZHENGXIANG DIAO WENRUI CHEN HONG SONG ZHENFENG TANG QIULING YU HEXIAN WANG QIANLI |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiang Zhengxiang Inventor after: Ding Qiuli Inventor after: Diao Wenrui Inventor after: Chen Hong Inventor after: Song Zhenfeng Inventor after: Yu Hexian Inventor after: Li Xinzhu Inventor after: Yu Xiuhua Inventor after: Liu Tongbin Inventor after: Wang Dejun Inventor before: Jiang Zhengxiang Inventor before: Diao Wenrui Inventor before: Chen Hong Inventor before: Song Zhenfeng Inventor before: Tang Qiuling Inventor before: Yu Hexian Inventor before: Wang Qianli |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIANG ZHENGXIANG DIAO WENRUI CHEN HONG SONG ZHENFENG TANG QIULING YU HEXIAN WANG QIANLI TO: JIANG ZHENGXIANG DIAO WENRUI CHEN HONG SONG ZHENFENG YU HEXIAN LI XINZHU YU XIUHUA LIU TONGBIN WANG DEJUN DING QIULI |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 Termination date: 20161125 |
|
CF01 | Termination of patent right due to non-payment of annual fee |